Our events

In Silico Approaches to Nitrosamine Risk Assessment — 2026 Webinar Series Nitrosamines continue to be one of the most challenging cross-functional issues facing the pharmaceutical industry, touching safety, quality, process development, and regulatory strategy.

強制分解の問題解決 This session will be hosted in Japanese or with Japanese subtitles. We are excited to host this webinar all about supporting forced degradation studies with in silico tools as part of your workflow.

The 10th Impurities: Genotoxic, Nitrosamine & Beyond Summit I #Egenotoxic 2026 is one of the most respected and widely attended gatherings in the field of pharmaceutical impurity control.

This webinar is a replay designed for our Japanese-speaking scientific community, with presentations available as recordings featuring embedded Japanese subtitles. The ICH S1B(R1) addendum is a globally recognised guideline that introduces a weight-of-evidence (WoE) approach to assessing the carcinogenic potential of pharmaceuticals. 

Save the date: Uncover best practices and new insights in chemical safety decision-making with Lhasa   Coming to Colombia on 10 March 2026!